Encompass Health Corporation EHC has expanded its inpatient rehabilitation footprint with the opening of Encompass Health Rehabilitation Hospital of Bangor in Maine. The 50-bed facility is now accepting patients and marks the company’s first wholly owned hospital in the state. The hospital provides specialized rehabilitation for patients recovering from strokes, brain injuries, spinal cord injuries, amputations and complex orthopedic conditions.
The hospital offers physical, occupational and speech therapy, along with 24-hour nursing care and frequent physician visits. Its facilities include private rooms, an advanced therapy gym, an activities of daily living suite, an in-house dialysis unit, a pharmacy and outdoor therapy areas. The location is also expected to expand access to post-acute rehabilitation while potentially easing capacity constraints at acute-care hospitals in the Bangor area.
The Bangor opening fits EHC’s broader strategy of adding capacity in markets where demand for inpatient rehabilitation remains favorable. In the second quarter of 2026, total discharges increased 5.6% year over year, while same-store discharges grew 2.8%, indicating that volume growth was driven by both new capacity and organic growth at existing hospitals. Net patient revenue per discharge also increased 3.9%, providing an additional boost to revenue growth.
EHC opened three hospitals totaling 139 beds in the first half of 2026 and added 54 beds through expansions at existing hospitals. The company plans to open eight new hospitals in 2026. The pace reflects EHC’s continued focus on growing its hospital network and increasing its bed capacity.
The Bangor facility could strengthen EHC’s long-term growth runway by adding capacity in a new wholly owned market while complementing its existing joint-venture presence in Portland. However, the returns from new hospitals will depend on how quickly beds ramp up and staffing costs are absorbed. With more openings planned this year, execution will remain key to sustaining EHC’s growth momentum.
EHC’s Price Performance
Year to date, EHC’s shares have gained 17.5% compared with the industry’s growth of 21%.
Image Source: Zacks Investment Research
EHC’s Zacks Rank & Other Key Picks
EHC currently carries a Zacks Rank #2 (Buy).
Some other top-ranked stocks in the Medical space are Concentra Group Holdings Parent, Inc. CON, Phibro Animal Health Corporation PAHC and GeneDx Holdings Corp. WGS, each sporting a Zacks Rank #1 (Strong Buy) at present. You can see the complete list of today’s Zacks #1 Rank stocks here.
The Zacks Consensus Estimate for Concentra Group’s current-year earnings of $1.65 per share has witnessed two upward revisions in the past 30 days against no movement in the opposite direction. CON beat earnings estimates in each of the trailing four quarters, with the average surprise being 16.3%. The consensus estimate for current-year revenues is pegged at $2.4 billion, suggesting 8.7% year-over-year growth.
The Zacks Consensus Estimate for Phibro Animal Health’s current-year earnings of $3.50 per share has witnessed one upward revision in the past 30 days against no movement in the opposite direction. PAHC beat earnings estimates in each of the trailing four quarters, with the average surprise being 18.4%. The consensus estimate for current-year revenues is pegged at $1.6 billion, suggesting 3.8% year-over-year growth.
The Zacks Consensus Estimate for GeneDx Holdings’ current-year earnings of 11 cents per share has witnessed one upward revision in the past 60 days against no movement in the opposite direction. WGS beat earnings estimates in three of the trailing four quarters and missed once. The consensus estimate for current-year revenues is pegged at $478 million, suggesting 11.8% year-over-year growth.
Zacks' Research Chief Names "Stock Most Likely to Double"
Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest.
Of course, all our elite picks aren't winners, but this one could far surpass earlier Zacks' Stocks Set to Double like D-Wave Quantum, which shot up +680.1%.
Free: See Our Top Stock And 4 Runners UpWant the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Encompass Health Corporation (EHC): Free Stock Analysis Report
Phibro Animal Health Corporation (PAHC): Free Stock Analysis Report
GeneDx Holdings Corp. (WGS): Free Stock Analysis Report
Concentra Group Holdings Parent, Inc. (CON): Free Stock Analysis Report
This article originally published on Zacks Investment Research (zacks.com).